First Trust Advisors LP Fulgent Genetics, Inc. Transaction History

First Trust Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$21.55 - $29.29 $66,093 - $89,832	3,067 Added 9.26%	36,190 $785,000
Q4 2023 Feb 13, 2024	BUY	$23.64 - $30.27 $783,027 - $1 Million	33,123 New	33,123 $957,000
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $255,846 - $430,053	-6,747 Reduced 8.69%	70,865 $2.7 Million
Q2 2022 Aug 12, 2022	BUY	$47.98 - $62.75 $1.28 Million - $1.67 Million	26,684 Added 52.4%	77,612 $4.23 Million
Q1 2022 May 13, 2022	BUY	$49.85 - $96.11 $99,450 - $191,739	1,995 Added 4.08%	50,928 $3.18 Million
Q4 2021 Feb 08, 2022	SELL	$77.3 - $105.0 $933,320 - $1.27 Million	-12,074 Reduced 19.79%	48,933 $4.92 Million
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $36,985 - $54,769	-494 Reduced 0.8%	61,007 $5.49 Million
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $4.11 Million - $6.18 Million	61,501 New	61,501 $5.67 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.